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Objective
• Reproduce published 
results of two in silico
models of severe sepsis
• Study relationship 
between model complexity 
and experimental 
outcomes
Methods
(1) Used original investigator’s agent-based model to re-run 
experiments; then ran same experiments with key model 
logic missing
(2) Implemented equations & parameters in original paper; 
later, obtained equations and #’s from the investigators and 
used them to run simulations
(3) Created very simple model; ran similar experiments
1 An, G (2004) "In silico experiments of existing and hypothetical Cytokine-directed clinical trials using agent based modeling” Crit Care Med 32(10):2050-2060.
2 Clermont, G, J Bartels, K Kumar, G Constantine, Y Vodovotz, C Chow (2004) “In silico design of clinical trials: A method coming of age” Crit Care Med 32(10):2061-2070.
3 Bernard G, J Vincent, P Laterre, et al (2001) “Efficacy and safety of recombinant human activated protein C for severe sepsis” N Engl J Med 344:699–709.
Background
Recent studies1,2 describe computer simulation models of the 
acute or systemic inflammatory response (AIR or SIR) to severe 
sepsis, a condition that can lead to multiple organ failure and 
death.  One study used an agent-based model, while the other 
used differential equations (DEs) to simulate a randomized clinical 
trial.  Both studies obtained results similar to the actual results 
from a successful clinical drug trial of severe sepsis3,, suggesting 
that in silico (simulated) randomized clinical trials may be used to 
design more effective in vivo clinical trials.
Results
(1) Agent-based model results 
successfully replicated. But 
nearly identical results were 
obtained with key portions of 
the model logic missing
(2) Unable to replicate the 
published DE model results 
due to numerous 
discrepancies in the equations 
and parameter values: 
simulated tissues always 
failed to recover
(3) Very simple model 
demonstrated outcomes 
ranging from full recovery to 
partial recovery (eradication of 
the initial infection, but oxygen 
deficit remains high) to failure 
to recover from the initial 
infection
Discussion/Conclusion
• Replicating outcomes from model-based research is important
• Researchers must determine the simplest model that can generate the phenomenon of interest
• More research needed before in silico experiments can be used to improve clinical trial design.
Very Simple Model and ResultsAgent Model Results
No support for 
hypothesis that 
results differ by 
parameter set 
number (α<.01)
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